<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
	<title>Financial Standard Comments - Super funds pay little attention to biotech</title>
	<description>Spray-on skin for burnt victims, cancer treatment drugs, the bionic ear - Australia's multi-billion dollar biotechnology sector is thriving but local investors are still shying away from the industry.</description>
	<link>https://www.financialstandard.com.au/feed/latest?story=11722</link>
	<lastBuildDate></lastBuildDate>
	<pubDate></pubDate>
	<language>en-AU</language>
	<copyright>Copyright 2026 Financial Standard</copyright>
	<ttl>5</ttl>
	<item>	</item>
</channel>
</rss>